ALFA Finder
17:26 IST
BSE
Other Announcement
Speciality Medicines Other Announcement
Speciality Medicines Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31.
Speciality Medicines Ltd
- Share price
- ₹161.00
- Market cap
- ₹141.4 Cr
- Revenue (annual)
- ₹75.29 Cr
- Net profit (annual)
- ₹13.03 Cr
- P/E (TTM)
- 10.8×Sector 43.8×
- Promoter holding
- 43.43%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 3New Order Win 2Financial Results 2Board Meeting Date 2Annual General Meeting 2Regulatory Approval 1Price Movement Clarification 1Business Update 1Annual Report 1
Time
3 announcements with these filters
18:28 IST
BSE
Other Announcement
Speciality Medicines Other Announcement
Speciality Medicines Limited has appointed Capital Bridge Advisory Service Private Limited as its Investor and Public Relations agency to enhance its investor relations and communication efforts.
16:33 IST
BSE
Other Announcement
Speciality Medicines Other Announcement
Speciality Medicines Ltd submitted contact details of Key Managerial Personnel authorised under SEBI Regulation 30(5). The authorised KMPs include the Chairman & Managing Director, Whole-time Director, and Company Secretary. This administrative update ensures compliance with materiality disclosure requirements.